Status:
UNKNOWN
The Recovery of Cardiovascular Patients With Depression
Lead Sponsor:
Klinički Bolnički Centar Zagreb
Conditions:
Coronary Artery Disease
Depression
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Cardiovascular disease increases the risk of depression and vice versa. Many cardiovascular patients are subjected to percutaneous coronary intervention (PCI). Potential biomarkers for the development...
Detailed Description
It has been shown that cardiovascular disease increases the risk of depression and vice versa. A significant proportion of cardiovascular diseases are coronary artery disease; most of these patients a...
Eligibility Criteria
Inclusion
- patients on day of percutaneous coronary intervention due to angina pectoris or myocardial infarction
- without antidepressant drugs or major tranquilizers more than one year
Exclusion
- symptoms of myocardial infarction lasting more than 12 hours
- left ventricle ejection function (LVEF) less than 40%
- earlier presence of cardiomyopathy
- acute infection
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03841474
Start Date
March 1 2021
End Date
November 1 2021
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KBC Zagreb
Zagreb, Croatia, 10000